Oncopeptides AB – Trademark Portfolio
Entity Type: 09
Oncopeptides AB holds 10 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 9 filings in this category. The portfolio also extends into Class 1 (Chemicals) across 4 Nice Classification classes. Currently, 6 trademarks are registered. Notable registered marks include TYGSIO, PEPAXTO, PEPZURVO, MELFLUFEN, and ONCOPEPTIDES.
Luntmakargatan 46
SE-111 37 Stockholm
Showing of trademarks Trademarks
Trademark Classifications
Oncopeptides AB's trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Scientific and technological services; industrial analysis and research services
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does Oncopeptides AB have?
Oncopeptides AB has 10 U.S. trademarks filed with the USPTO. Of these, 6 registered, 1 abandoned.
What trademark classes does Oncopeptides AB file in?
Oncopeptides AB files trademarks across 4 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 1 (Chemicals), Class 42 (Computer & Scientific), Class 44 (Medical Services). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Oncopeptides AB's most well-known trademarks?
Oncopeptides AB's registered trademark portfolio includes well-known marks such as TYGSIO, PEPAXTO, PEPZURVO, MELFLUFEN, and ONCOPEPTIDES. These are among 6 currently registered trademarks in the portfolio.
What is Oncopeptides AB's trademark registration success rate?
Oncopeptides AB has a 86% trademark registration rate, with 6 out of 7 resolved applications resulting in successful registration. Currently, 0 applications are pending review.